# An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder

> **NCT05254405** · PHASE4 · RECRUITING · sponsor: **Donald Jeffrey Newport** · enrollment: 20 (estimated)

## Conditions studied

- Post-Traumatic Stress Disorder

## Interventions

- **DRUG:** Brexanolone Injection [Zulresso]

## Key facts

- **NCT ID:** NCT05254405
- **Lead sponsor:** Donald Jeffrey Newport
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254405, "An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05254405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*